Sakar Healthcare Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Consolidated and Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025".
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare has submitted a press release dated February 5, 2026, to the stock exchange covering its consolidated and standalone unaudited financial results for the quarter and nine months ended December 31, 2025. The filing itself does not include specific numbers such as revenue, profit, or margins — it only references the attached press release. Investors will need to refer to the detailed results document for the actual financial figures and performance commentary. This is part of the company's standard quarterly disclosure obligations under listing rules.
Neutral on its own, as this is just a notice of an attached press release. The real impact depends on the actual numbers reported — investors should watch for revenue growth, margin trends, and any management guidance in the detailed results.